SCHEMBL31663533

SCHEMBL31663533

Cc1ccc2c(c1)c1ccccc1n2-c1ccccc1-c1cccc(C#N)c1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.39
PDE1C Q14123 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HIF1A Q16665 1/20 0.38
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
GABRA1 P14867 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
MAOA P21397 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MDM2 Q00987 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273030 0.86 PDE9A (0.39) PDE9APDE1CPTGDR2SMN1; SMN2LMNA
SCHEMBL31272663 0.86 PDE9A (0.39) PDE9APDE1CPTGDR2SMN1; SMN2LMNA
SCHEMBL31663554 0.86 PDE9A (0.40) PDE9APDE1CPTGDR2SMN1; SMN2LMNA
SCHEMBL31663632 0.86 PDE9A (0.40) PDE9APDE1CPTGDR2SMN1; SMN2LMNA
SCHEMBL19755360 0.84 KDM4E (0.42) SMN1; SMN2HIF1AKDM4EALDH1A1HTR7
SCHEMBL27016023 0.84 PTGDR2 (0.36) PTGDR2SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL22378637 0.84 KDM4E (0.37) SMN1; SMN2HIF1ALMNAGABRA1GABRG2
SCHEMBL24927640 0.83 SMN1; SMN2 (0.39) SMN1; SMN2HIF1AMAPTGABRG2GABRB3
SCHEMBL22377456 0.83 MCL1 (0.37) SMN1; SMN2HIF1AMAPTGABRA1GABRG2
SCHEMBL22327522 0.83 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AMAPTGABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 PDE9A 4069/4885PDE1C 4875/4885PTGDR2 3664/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 PDE9A 4069/4885PDE1C 4875/4885PTGDR2 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.